BR9709316A - Composição farmacêutica para administração tópica no tratamento da vaginite - Google Patents

Composição farmacêutica para administração tópica no tratamento da vaginite

Info

Publication number
BR9709316A
BR9709316A BR9709316-5A BR9709316A BR9709316A BR 9709316 A BR9709316 A BR 9709316A BR 9709316 A BR9709316 A BR 9709316A BR 9709316 A BR9709316 A BR 9709316A
Authority
BR
Brazil
Prior art keywords
vaginitis
treatment
pharmaceutical composition
topical administration
benzocaine
Prior art date
Application number
BR9709316-5A
Other languages
English (en)
Inventor
Koral Embil
Oswald Morton
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9709316(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of BR9709316A publication Critical patent/BR9709316A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA ADMINISTRAçãO TóPICA NO TRATAMENTO DA VAGINITE". Composição farmacêutica para administração tópica no tratamento da vaginite, compreendendo um ou mais medicamentos antivaginite, tais como, metronidazola e miconazola, e um ou mais anestésicos locais, tais como, lidocaína ou benzocaína.
BR9709316-5A 1996-05-17 1997-05-16 Composição farmacêutica para administração tópica no tratamento da vaginite BR9709316A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions
PCT/GB1997/001355 WO1997044032A1 (en) 1996-05-17 1997-05-16 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics

Publications (1)

Publication Number Publication Date
BR9709316A true BR9709316A (pt) 2000-05-02

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709316-5A BR9709316A (pt) 1996-05-17 1997-05-16 Composição farmacêutica para administração tópica no tratamento da vaginite

Country Status (12)

Country Link
EP (1) EP0910377A1 (pt)
JP (1) JP2000513334A (pt)
CN (1) CN1127338C (pt)
AU (1) AU2905597A (pt)
BR (1) BR9709316A (pt)
GB (1) GB9610359D0 (pt)
ID (1) ID16929A (pt)
MY (1) MY127711A (pt)
RU (1) RU2195281C2 (pt)
TR (1) TR199802351T2 (pt)
WO (1) WO1997044032A1 (pt)
ZA (1) ZA974266B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20050095245A1 (en) 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
CN1291754C (zh) * 2005-07-12 2006-12-27 李赴朝 局麻药增效延时剂
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
EP1968544A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
RU2603490C1 (ru) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2605343C1 (ru) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
PT3481370T (pt) 2016-07-08 2021-05-28 Acraf Composição farmacêutica compreendendo benzidamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
CN1127338C (zh) 2003-11-12
WO1997044032A1 (en) 1997-11-27
JP2000513334A (ja) 2000-10-10
MY127711A (en) 2006-12-29
AU2905597A (en) 1997-12-09
GB9610359D0 (en) 1996-07-24
ID16929A (id) 1997-11-20
RU2195281C2 (ru) 2002-12-27
EP0910377A1 (en) 1999-04-28
TR199802351T2 (xx) 1999-03-22
ZA974266B (en) 1998-11-16
CN1223581A (zh) 1999-07-21

Similar Documents

Publication Publication Date Title
BR9709316A (pt) Composição farmacêutica para administração tópica no tratamento da vaginite
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
RS49721B (sr) Kompozicija koja sadrži biljku i površinski aktivno sredstvo korisna u proizvodnji proizvoda za tretiranje herpesa i drugih mikrobnih infekcija
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FR11C0006I1 (fr) Administration amelioree de medicaments sur des muqueuses
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
DK0770384T3 (da) Faste, vandfrie farmaceutiske sammensætninger til vaginal anvendelse
DE69825164D1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
AR008797A1 (es) Composicion.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DE69705110D1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
ES2126760T3 (es) Nuevo ansiolitico.
ATE218881T1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
ATE277622T1 (de) Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide
UA30524A (uk) Мазь для лікування гіперкератозів
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B12B Appeal: appeal against refusal